EXICURE INC XCUR
COM · Common Stock · CUSIP 30205M101
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersChicago, IL
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.12.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 45 |
| Q1 2020 | 52 |
| Q2 2020 | 66 |
| Q3 2020 | 64 |
| Q4 2020 | 68 |
| Q1 2021 | 72 |
| Q2 2021 | 59 |
| Q3 2021 | 48 |
| Q4 2021 | 49 |
| Q1 2022 | 44 |
| Q2 2022 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 18 | 27 |
| Q4 2020 | 30 | 18 |
| Q1 2021 | 30 | 25 |
| Q2 2021 | 22 | 43 |
| Q3 2021 | 16 | 30 |
| Q4 2021 | 21 | 21 |
| Q1 2022 | 17 | 19 |
| Q2 2022 | 0 | 43 |
Biggest buyers
| None |
Biggest sellers
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | Sold out | -7.3m |
| Abingworth LLP | Reduced | -6.7m |
| VANGUARD GROUP INC | Sold out | -2.8m |
| NORTHWESTERN UNIVERSITY | Reduced | -1.5m |
| Carlson Capital, L.P. | Sold out | -1.4m |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -1.4m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -667.0k |
| Sigma Planning Corp | Sold out | -519.5k |
| BlackRock Inc. | Sold out | -518.5k |
| CITADEL ADVISORS LLC | Sold out | -469.4k |
Insider purchases and sales in Q2 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 1 | $13.8k | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 1 | $279.7k | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-05-19 | Muralidhar Bali Director · See footnotes | Bought | $279.7k1.5m shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Abingworth LLP 0.19% of their portfolio | 281.6k $594.0k | Reduced -6.7m |
| NORTHWESTERN UNIVERSITY 0.12% of their portfolio | 52.1k $113.0k | Reduced -1.5m |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC 0.00% of their portfolio | 36.8k $79.0k | Unchanged |